Oral formulations Moving beyond injections Historically, GLP-1 drugs have been injectable because peptides are broken down in the digestive tract before they can be absorbed
When the glucose tank is empty, the body switches to the muscle tank and then the fat tank for energy production
19 In addition, the coformulation of SNAC and semaglutide was shown to have no extended effect on stomach mucosa
The GLP-1 Revolution Driving Growth Lilly dominates the obesity and diabetes market with two blockbuster drugs that are rewriting treatment paradigms: Mounjaro (Type 2 Diabetes) + Zepbound (Obesity) = $10.1B in Q3 2025 revenues (+131% YoY) Mounjaro: $6.52B (+109% YoY) Zepbound: $3.59B (+184% YoY) For context: This tirzepatide franchise just surpassed Merck's Keytruda ($8.1B in Q3) to become the world's best-selling drug
Thats why our weight programs incorporate medications that may include compounded GLP-1s, if your clinician determines theyre right for you
This approach helps reinforce circadian stability, leading to more predictable energy levels and smoother metabolic function